Dose of hemodialysis and survival: A marginal structural model analysis

American Journal of Nephrology

Volumn 39, Issue 5, 2014, Pages 383-391

  Lertdumrongluk, Paungpaga ^a,h   Streja, Elani ^a   Rhee, Connie M ^a,b   Park, Jongha ^a,i   Arah, Onyebuchi A ^c   Brunelli, Steven M ^e,g   Nissenson, Allen R ^d,e   Gillen, Daniel ^f   Kalantar Zadeh, Kamyar ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DAVITA INC   (United States)

^f 5226 Donald Bren Hall   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h SRINAKHARINWIROT UNIVERSITY   (Thailand)

ⁱ University of Ulsan College of Medicine   (South Korea)

Author keywords

Hemodialysis adequacy; Hemodialysis dose; Marginal structural model; Mortality; Survival

Indexed keywords

ALBUMIN; CREATININE; PHOSPHORUS;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; BODY SIZE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MARGINAL STRUCTURAL MODEL; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT DURATION; CORRELATION ANALYSIS; MIDDLE AGED; RISK REDUCTION; STATISTICAL MODEL; KIDNEY FAILURE, CHRONIC; PROCEDURES; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY;

ADULT; AGED; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84899615517     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000362285     Document Type: Article

References (37)

1. Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006. Am J Kidney Dis 2006; 48(suppl 1):S2-S90.
2. Daugirdas JT: The post-:pre-dialysis plasma urea nitrogen ratio to estimate Kt/V and NPCR: mathematical modeling. Int J Artif Organs 1989; 12: 411-419. (Pubitemid 19185306)
3. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-534. (Pubitemid 15248043)
4. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-2019. (Pubitemid 35461657)
5. Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994; 23: 272-282. (Pubitemid 24075323)
6. Hakim RM, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994; 23: 661-669. (Pubitemid 24138419)
7. Owen WF Jr, Chertow GM, Lazarus JM, Lowrie EG: Dose of hemodialysis and survival: differences by race and sex. JAMA 1998; 280: 1764-1768. (Pubitemid 28536877)
8. Parker TF 3rd, Husni L, Huang W, Lew N, Lowrie EG: Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994; 23: 670-680. (Pubitemid 24138420)
9. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002; 13: 1061-1066. (Pubitemid 34274104)
10. Shinzato T, Nakai S, Akiba T, Yamazaki C, Sasaki R, Kitaoka T, Kubo K, Shinoda T, Kurokawa K, Marumo F, Sato T, Maeda K: Survival in long-term haemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1997; 12: 884-888. (Pubitemid 27216307)
11. Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK: Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 2000; 35: 80-88. (Pubitemid 30027244)
12. Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW: Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2001; 16: 2386-2394. (Pubitemid 33133852)
13. Chertow GM, Owen WF, Lazarus JM, Lew NL, Lowrie EG: Exploring the reverse Jshaped curve between urea reduction ratio and mortality. Kidney Int 1999; 56: 1872-1878. (Pubitemid 29518188)
14. Salahudeen AK, Dykes P, May W: Risk factors for higher mortality at the highest levels of spKt/V in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 1339-1344. (Pubitemid 36826955)
15. Fung F, Sherrard DJ, Gillen DL, Wong C, Kestenbaum B, Seliger S, Ball A, Stehman-Breen C: Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis 2002; 40: 307-314. (Pubitemid 34827648)
16. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S: Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 2005; 20: 1880-1888. (Pubitemid 41222603)
17. Pifer TB, McCullough KP, Port FK, Goodkin DA, Maroni BJ, Held PJ, Young EW: Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 2002; 62: 2238-2245. (Pubitemid 35366181)
18. Robins JM, Hernan MA, Brumback B: Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11: 550-560. (Pubitemid 30660034)
19. Joffe MM, Ten Have TR, Feldman HI, Kimmel SE: Model selection, confounder control, and marginal structural models: review and new applications. Am Stat 2004; 58: 272-279. (Pubitemid 39525979)
20. Streja E, Kovesdy CP, Molnar MZ, Norris KC, Greenland S, Nissenson AR, Kopple JD, Kalantar-Zadeh K: Role of nutritional status and inflammation in higher survival of African-American and Hispanic hemodialysis patients. Am J Kidney Dis 2011; 57: 883-893.
21. Miller JE, Molnar MZ, Kovesdy CP, Zaritsky JJ, Streja E, Salusky I, Arah OA, Kalantar-Zadeh K: Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis. Pharmacoepidemiol Drug Saf 2012; 21: 1232-1239.
22. Van der Wal WM, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT, Korevaar JC, Geskus RB: Comparing mortality in renal patients on hemodialysis versus peritoneal dialysis using a marginal structural model. Int J Biostat 2010; 6:Article 2.
23. Daugirdas JT: Second-generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213.
24. Lukowsky LR, Mehrotra R, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K: Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis. Clin J Am Soc Nephrol 2013; 8: 619-628.
25. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E: Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 2011; 171: 110-118.
26. Molnar MZ, Kalantar-Zadeh K, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Quarles DL, Kovesdy CP: ACE inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol 2014; 63: 650-658.
27. Greene T, Daugirdas J, Depner T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek JW, Levin N, Owen W, Schulman G, Star R, Toto R, Eknoyan G: Association of achieved dialysis dose with mortality in the hemodialysis study: an example of 'dose-targeting bias'. J Am Soc Nephrol 2005; 16: 3371-3380. (Pubitemid 46187551)
28. Robins JM: Correction for non-compliance in equivalence trials. Stat Med 1998; 17: 269-302; discussion 387-269. (Pubitemid 28051099)
29. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, Thadhani R: Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005; 16: 1115-1125. (Pubitemid 41710323)
30. Weinhandl ED, Rao M, Gilbertson DT, Collins AJ, Pereira BJ: Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003. Am J Kidney Dis 2007; 50: 803-812. (Pubitemid 47588551)
31. Ramirez SP, Kapke A, Port FK, Wolfe RA, Saran R, Pearson J, Hirth RA, Messana JM, Daugirdas JT: Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality. Clin J Am Soc Nephrol 2012; 7: 1977-1987.
32. Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB, Fonarow GC: Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 2009; 119: 671-679.
33. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006; 69: 1222-1228.
34. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 2009; 4: 914-920.
35. Port FK, Wolfe RA, Hulbert-Shearon TE, Mc-Cullough KP, Ashby VB, Held PJ: High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis 2004; 43: 1014-1023. (Pubitemid 38691496)
36. Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, Powe NR, Coresh J: Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: The choices for healthy outcomes in caring for end-stage renal disease (choice) study. Am J Kidney Dis 2010; 56: 348-358.
37. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD: Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003; 42: 864-881. (Pubitemid 37322905)